Nuvama Wealth Management Grants 93,930 Employee Stock Appreciation Rights Under ESAR Plan 2024
Nuvama Wealth Management Limited granted 93,930 Employee Stock Appreciation Rights to eligible employees on May 11, 2026, under the Nuvama Wealth Employee Stock Appreciation Rights Plan 2024. The grant, covering not more than 93,930 equity shares, is compliant with SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021, and is administered by the Nomination and Remuneration Committee. The ESAR price is determined based on the average of daily opening and closing prices over 20 trading days prior to the relevant date. Settled in equity shares upon exercise, the ESARs carry an exercise window of 2 years from the date of vesting.

*this image is generated using AI for illustrative purposes only.
Nuvama Wealth Management Limited announced on May 11, 2026, the grant of 93,930 Employee Stock Appreciation Rights (ESARs) to eligible employees under the 'Nuvama Wealth Employee Stock Appreciation Rights Plan 2024'. The disclosure was made pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, and in accordance with SEBI Master Circular No. SEBI/HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026.
Key Details of the ESAR Grant
The grant covers not more than 93,930 equity shares of the company and is compliant with the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021. The following table summarises the key parameters of the grant:
| Parameter: | Details |
|---|---|
| Number of ESARs Granted: | 93,930 |
| Total Shares Covered: | Not more than 93,930 equity shares |
| Grant Date: | May 11, 2026 |
| Plan Name: | Nuvama Wealth Employee Stock Appreciation Rights Plan 2024 |
| ESARs Vested: | Nil |
| Exercise Period: | 2 years from the date of vesting |
| Administering Body: | Nomination and Remuneration Committee |
| SEBI Regulations Compliance: | SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021 |
Pricing Formula and Settlement Terms
The ESAR price for each grant is determined by the Nomination and Remuneration Committee. It is calculated as the average of the daily opening and closing price of the company's equity shares, as quoted on the recognised stock exchange where the trading volume is higher, across each of the 20 trading days immediately prior to the relevant date.
Once vested and exercised, the ESARs entitle the holder to receive appreciation on a specified number of equity shares of the company. Settlement of such appreciation is made in the form of equity shares of the company, upon payment of the exercise price and applicable taxes, in accordance with the terms and conditions of the Plan.
Applicable Disclosures
Since the current disclosure pertains solely to the grant of ESARs, several parameters are not applicable at this stage. These include:
- ESARs exercised
- Money realised by exercise of ESARs
- Total shares arising from exercise of ESARs
- ESARs lapsed
- Subsequent changes, cancellation, or exercise of ESARs
- Diluted earnings per share pursuant to the issue of equity shares on exercise of ESARs
No variation of terms has been reported in connection with this grant. The disclosure was signed by Sneha Patwardhan, Company Secretary and Compliance Officer of Nuvama Wealth Management Limited.
How might the vesting schedule and exercise timeline of these ESARs influence employee retention rates at Nuvama Wealth Management over the next 2-3 years?
Given that settlement is made in equity shares rather than cash, what potential dilution impact could future ESAR exercises have on existing shareholders of Nuvama Wealth Management?
How does Nuvama Wealth Management's ESAR grant size and structure compare to similar employee incentive programs offered by competing wealth management firms in India?




























